Amban, Flordeliza S.

HRN: 23 11 82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2023
06/03/2023
IV
500 Mg
Q8h
T/C Acute Appemdicitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: